Jul 23 2007
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc., announced today a new division to the Company. As of July 15, Dr. Saju Nettikadan is director of the “Emerging Technologies” division of BioForce. Dr. Nettikadan will oversee the division dedicated to commercializing in-house research and development efforts, enabling collaborations with external R&D consumers of BioForce's instruments. Dr. Nettikadan has been an integral employee of BioForce for nearly nine years and has been the project director for the previously publicized ViriChip™ platform and Chip-on-a-Tip™ projects. He holds a doctorate from The Ohio State University.
BioForce Nanosciences develops and commercializes nanotech tools and solutions for the life sciences. BioForce’s flagship product, the Nano eNabler™ molecular printer, gives the Company a unique platform for development and discovery. Anticipated scientific applications developed within the BioForce laboratory or in user’s laboratories have the potential for significant future revenue.
BioForce’s President and Chief Operating Officer Kerry Frey noted, “It’s very exciting to be at a point in BioForce’s progression to be seeing results with the Nano eNabler™ system sales and anticipating increased results from our heightened focus on Emerging Technologies.”